Corbin, A E <br/><br/>
Pharmacological characterization of PD 152255, a novel dimeric benzimidazole dopamine D3 antagonist.  [electronic resource] 

 -  Pharmacology, biochemistry, and behavior  Feb 1998 
 - 487-93 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0091-3057 
<br/><br/><label>Standard No.: </label>10.1016/s0091-3057(97)00442-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antipsychotic Agents--pharmacology<br/>Benzimidazoles--pharmacology<br/>Biogenic Monoamines--biosynthesis<br/>Brain Chemistry--drug effects<br/>CHO Cells<br/>Cholinergic Antagonists--pharmacology<br/>Cricetinae<br/>Dopamine Antagonists--pharmacology<br/>Dopamine D2 Receptor Antagonists<br/>Dose-Response Relationship, Drug<br/>Male<br/>Mice<br/>Motor Activity--drug effects<br/>Piperidines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine D3<br/>Signal Transduction--drug effects<br/>Thymidine--metabolism